18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Clinical trial NCT02348749 · COMPLETED

Trial details

NCT number: NCT02348749
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2015-01-01
Primary completion: 2025-03-17
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.